Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yiming Zhang
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
University of Connecticut
ORCID:
0000-0002-1364-3051
Observed ORCID:
0000-0002-1364-3051
OpenAlex ID:
A5021900997
The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial
2022
·
Jie Chen
, Yiming Zhang
, et al.
·
International Journal of Nursing Studies
·
33
PDF
Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
·
Clinical Cancer Research
·
7
Data from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S6 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S1 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S7 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S3 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Table S1 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Data S1 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S5 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S2 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Supplementary Figure S4 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
2025
·
Kai Chen
, Ting-Yu Chen
, et al.
Show more works
View as search
Works count:
12
Citation count:
40
H-index:
2
I10-index:
1
Year
Topic
Type